Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Pediatric Hematology/Oncology
•
Neurology
•
Child Neurology
•
Pediatric Oncology
•
Neurodevelopmental Disabilities
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
Related Questions
What pharmacological management do you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
How do you decide when to pursue genetic testing for cerebral palsy?
How do you counsel parents of patients with Autism Spectrum Disorder regarding the limitations of medications without engaging in behavioral or family interventions?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
When do you consider testing with stroke gene panels in young stroke patients?
For what patients/diagnoses do you currently use sodium thiosulfate to reduce the risk of cisplatin associated ototoxicity?
For a patient with large volume glioblastoma, what do you do if they are found to have a subdural infection in the middle of chemoRT requiring repeat surgery?
How do you manage follow up for patient who was diagnosed with pineal gland germinomas with drop metastatic to the spinal cord?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Would you start antiseizure medications in tuberous sclerosis before seizure onset?
